Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-11-18 Sale |
2024-11-20 4:05 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, COO and CFO |
11,001 | $4.08 | $44,884 | 309,572 (Direct) |
View |
| 2024-03-04 Purchase |
2024-03-06 4:05 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer |
10,684 | $9.38 | $100,216 | 301,733 (Direct) |
View |
| 2023-09-15 Purchase |
2023-09-18 5:07 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer |
36,072 | $8.32 | $300,119 | 188,730 (Direct) |
View |
| 2022-11-21 Sale |
2022-11-23 4:05 pm |
IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer |
6,578 | $11.56 | $76,042 | 78,422 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-12-31 Option Award |
2025-01-02 8:04 pm |
N/A 2034-12-31 |
Beam Therapeutics Inc. | BEAM | Emany Sravan Kumar Chief Financial Officer |
240,000 | $0 | 240,000 (Direct) |
View |
| 2024-05-23 Option Award |
2024-05-28 8:02 pm |
N/A 2034-05-23 |
Assertio Holdings Inc. | ASRT | Emany Sravan Kumar Director |
134,975 | $0 | 312,545 (Direct) |
View |
| 2024-05-16 Tax Withholding |
2024-05-20 4:05 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer |
18,280 | $6.64 | 320,573 (Direct) |
View |
| 2024-03-08 Exercise |
2024-03-12 4:05 pm |
N/A 2026-02-28 |
IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer |
37,120 | $0 | 338,853 (Direct) |
View |
| 2024-02-12 Option Award |
2024-02-14 8:39 pm |
N/A 2027-02-28 |
IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer |
97,968 | $0 | 323,705 (Direct) |
View |
| 2024-02-08 Tax Withholding |
2024-02-12 4:05 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer |
41,332 | $14.9 | 225,737 (Direct) |
View |
| 2024-01-17 Option Award |
2024-01-19 4:05 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer |
85,000 | $0 | 267,069 (Direct) |
View |
| 2023-11-16 Tax Withholding |
2023-11-20 4:05 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer |
6,661 | $9.44 | 182,069 (Direct) |
View |
| 2023-11-14 Option Award |
2023-11-16 8:05 pm |
N/A 2023-11-14 |
Assertio Holdings Inc. | ASRT | Emany Sravan Kumar Director |
203,878 | $0 | 203,878 (Direct) |
View |
| 2023-03-08 Option Award |
2023-03-10 5:08 pm |
N/A 2026-02-28 |
IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer |
111,354 | $0 | 189,776 (Direct) |
View |
| 2021-12-06 Option Award |
2021-12-08 4:09 pm |
N/A N/A |
IRONWOOD PHARMACEUTICALS INC | IRWD | Emany Sravan Kumar SVP, Chief Financial Officer |
85,000 | $0 | 85,000 (Direct) |
View |